Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $9.3900 (2.12%) ($9.3900 - $9.3900) on Tue. Mar. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.95% (three month average) | RSI | 35 | Latest Price | $9.3900(2.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -1.7% a day on average for past five trading days. | Weekly Trend | FOLD declines -6% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(57%) IWO(54%) XBI(51%) IWC(50%) IWM(50%) | Factors Impacting FOLD price | FOLD will decline at least -2.475% in a week (0% probabilities). VIXM(-30%) VXX(-14%) UUP(-12%) UNG(-6%) TLT(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.475% (StdDev 4.95%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.08(-100.85%) | Resistance Level | $10.16 | 5 Day Moving Average | $9.41(-0.21%) | 10 Day Moving Average | $9.83(-4.48%) | 20 Day Moving Average | $10.16(-7.58%) | To recent high | -60.6% | To recent low | 2.1% | Market Cap | $2.425b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |